Enteropeptidase boropeptide inhibitors and their uses in treatments of obesity, overweight and / or diseases associated with an abnormal fat metabolism
A compound selected from the group consisting of Glu-Gly-Boro-Arg, Ala-Phe-Boro-Arg, Ac-Glu-Gly-Boro-Arg, and Ac-Ala-Phe-Boro-Arg, where Ac is acetyl .